United States · FDA National Drug Code directory

Calcipotriene and Betamethasone Dipropionate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 51672-1402_38e5b828-cecd-c95b-e063-6394a90ae2e0
Product NDC: 51672-1402
Form: SUSPENSION
Composition / generic term: Calcipotriene and Betamethasone Dipropionate
Labeler: Sun Pharmaceutical Industries, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20200902
Source listing expiry: 20261231

Source-listed ingredients

CALCIPOTRIENE — 50 ug/g
BETAMETHASONE DIPROPIONATE — 50 mg/g

These values do not establish equivalence or a dose recommendation.

Packages

1 BOTTLE in 1 CARTON (51672-1402-4) / 60 g in 1 BOTTLE · 51672-1402-4
2 BOTTLE in 1 CARTON (51672-1402-8) / 60 g in 1 BOTTLE · 51672-1402-8

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →